---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-121182"
form_type: "8-K"
ticker: "ZBIO"
cik: "0001953926"
company_name: "Zenas BioPharma, Inc."
filed_at: "2025-12-15T23:59:59+00:00"
generated_at: "2026-05-16T13:16:02.158728+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Zenas BioPharma adopts 2026 Inducement Plan for up to 1M shares for new hires

## Summary
- Plan reserves 1,000,000 shares of common stock for equity awards to new employees as hiring inducements.
- Approved Dec 10, 2025 by Board; requires Compensation Committee or independent director approval per Nasdaq Rule 5635(c)(4).
- Plan exempt from stockholder approval; grants include non-statutory stock options, SARs, RSUs, and restricted stock.
- Eligible individuals are new hires or rehires after a bona fide break in employment.

## SEC filing metadata
- accession: 0001104659-25-121182
- form_type: 8-K
- ticker: ZBIO
- cik: 0001953926
- company_name: Zenas BioPharma, Inc.
- filed_at: 2025-12-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1953926/000110465925121182/0001104659-25-121182-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1953926/000110465925121182/tm2533427d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-121182
- JSON: https://secwatch.observer/filing/0001104659-25-121182.json
- Plain text: https://secwatch.observer/filing/0001104659-25-121182.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.